MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
18.80
+0.05 (0.27%)
Aug 14, 2025, 11:45 AM - Market open
MediWound Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 19.86 | 20.22 | 18.69 | 26.5 | 23.76 | 21.76 | Upgrade | |
Revenue Growth (YoY) | -1.41% | 8.22% | -29.48% | 11.50% | 9.19% | -31.54% | Upgrade |
Cost of Revenue | 16.2 | 17.59 | 15.11 | 13.33 | 14.99 | 14.22 | Upgrade |
Gross Profit | 3.66 | 2.63 | 3.58 | 13.17 | 8.77 | 7.55 | Upgrade |
Selling, General & Admin | 13.87 | 13.14 | 11.61 | 10.65 | 9.74 | 8.69 | Upgrade |
Research & Development | 11.89 | 8.88 | 7.47 | 10.18 | 10.26 | 7.7 | Upgrade |
Other Operating Expenses | 0.02 | 0.02 | - | - | - | - | Upgrade |
Operating Expenses | 25.78 | 22.03 | 19.08 | 20.83 | 19.99 | 16.39 | Upgrade |
Operating Income | -22.12 | -19.4 | -15.5 | -7.66 | -11.22 | -8.84 | Upgrade |
Interest Expense | - | -0.53 | -0.27 | -0.1 | -0.12 | -0.83 | Upgrade |
Interest & Investment Income | 6.26 | 2.05 | 2.34 | 0.27 | 0.01 | 0.3 | Upgrade |
Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.65 | 0.06 | -0.51 | 0.11 | Upgrade |
Other Non Operating Income (Expenses) | -12.26 | -12.26 | -0.96 | -11.4 | -0.19 | -0.45 | Upgrade |
EBT Excluding Unusual Items | -28.15 | -30.16 | -15.05 | -18.84 | -12.03 | -9.71 | Upgrade |
Other Unusual Items | - | - | 8.52 | -0.68 | -1.49 | 0.43 | Upgrade |
Pretax Income | -28.15 | -30.16 | -6.53 | -19.52 | -13.52 | -9.28 | Upgrade |
Income Tax Expense | 0.08 | 0.06 | 0.19 | 0.08 | 0.03 | - | Upgrade |
Earnings From Continuing Operations | -28.23 | -30.22 | -6.72 | -19.6 | -13.55 | -9.28 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | 0.08 | Upgrade |
Net Income | -28.23 | -30.22 | -6.72 | -19.6 | -13.55 | -9.2 | Upgrade |
Net Income to Common | -28.23 | -30.22 | -6.72 | -19.6 | -13.55 | -9.2 | Upgrade |
Shares Outstanding (Basic) | 11 | 10 | 9 | 5 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 11 | 10 | 9 | 5 | 4 | 4 | Upgrade |
Shares Change (YoY) | 16.23% | 10.50% | 80.73% | 28.13% | 0.24% | - | Upgrade |
EPS (Basic) | -2.63 | -3.03 | -0.75 | -3.93 | -3.48 | -2.37 | Upgrade |
EPS (Diluted) | -2.63 | -3.03 | -0.75 | -3.93 | -3.48 | -2.37 | Upgrade |
Free Cash Flow | -19.27 | -19.9 | -16.93 | -12.44 | -9.41 | -7.82 | Upgrade |
Free Cash Flow Per Share | -1.79 | -2.00 | -1.88 | -2.49 | -2.42 | -2.01 | Upgrade |
Gross Margin | 18.43% | 13.03% | 19.15% | 49.69% | 36.91% | 34.67% | Upgrade |
Operating Margin | -111.41% | -95.94% | -82.95% | -28.91% | -47.22% | -40.62% | Upgrade |
Profit Margin | -142.18% | -149.46% | -35.94% | -73.97% | -57.03% | -42.25% | Upgrade |
Free Cash Flow Margin | -97.01% | -98.39% | -90.60% | -46.95% | -39.58% | -35.92% | Upgrade |
EBITDA | -21.28 | -18.58 | -14.76 | -6.39 | -9.98 | -7.75 | Upgrade |
EBITDA Margin | -107.15% | -91.88% | -79.01% | -24.11% | -42.01% | -35.61% | Upgrade |
D&A For EBITDA | 0.85 | 0.82 | 0.74 | 1.27 | 1.24 | 1.09 | Upgrade |
EBIT | -22.12 | -19.4 | -15.5 | -7.66 | -11.22 | -8.84 | Upgrade |
EBIT Margin | -111.41% | -95.94% | -82.95% | -28.91% | -47.22% | -40.62% | Upgrade |
Revenue as Reported | 20.22 | 20.22 | 18.69 | 26.5 | 23.76 | 21.76 | Upgrade |
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.